Targeting transporters: Promoting blood-brain barrier repair in response to oxidative stress injury

Brain Research

Volumn 1623, Issue , 2015, Pages 39-52

  Ronaldson, Patrick T ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bloodbrain barrier; Endothelial cell; Membrane transporter; Multidrug resistance proteins; Organic anion transporting polypeptides; Oxidative stress

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; GLUTATHIONE; SOLUTE CARRIER TRANSPORTER; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN INJURY; CELL INTERACTION; CELL JUNCTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; OXIDATIVE STRESS;

EID: 84941316599     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.03.018     Document Type: Review

References (170)

1. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol. Dis. 37 2010 13 25
2. T.J. Abbruscato, S.P. Lopez, K.S. Mark, B.T. Hawkins, and T.P. Davis Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells J. Pharm. Sci. 91 2002 2525 2538
3. S. Agarwal, R. Sane, J.R. Ohlfest, and W.F. Elmquist The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain J. Pharmacol. Exp. Ther. 336 2011 223 233
4. L.M. Aleksunes, A.L. Slitt, J.M. Maher, L.M. Augustine, M.J. Goedken, J.Y. Chan, N.J. Cherrington, C.D. Klaassen, and J.E. Manautou Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2 Toxicol. Appl. Pharmacol. 226 2008 74 83
5. A. Alfieri, S. Srivastava, R.C.M. Siow, M. Modo, P.A. Fraser, and G.E. Mann Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke J. Physiol. 58 2011 4125 4136
6. N. Ballatori, S.M. Krance, R. Marchan, and C.L. Hammond Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology Mol. Asp. Med. 30 2009 13 28
7. P.E. Bandler, C.J. Westlake, C.E. Grant, S.P. Cole, and R.G. Deeley Identification of regions required for apical membrane localization of human multidrug resistance protein 2 Mol. Pharmacol. 74 2008 9 19
8. E. Barone, G. Cenini, F. Di Domenico, S. Martin, R. Sultana, C. Mancuso, M.P. Murphy, E. Head, and D.A. Butterfield Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action Pharmacol. Res. 63 2011 172 180
9. B. Bauer, A.M. Hartz, J.R. Lucking, X. Yang, G.M. Pollack, and D.S. Miller Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier J. Cereb. Blood Flow Metab. 28 2008 1222 1234
10. H.C. Bauer, I.A. Krizbal, H. Bauer, and A. Traweger "You shall not pass"-tight junctions of the blood brain barrier Front. Neurosci. 8 2014 392
11. E. Beaulieu, M. Demeule, L. Ghitescu, and R. Beliveau P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain Biochem. J. 326 1997 539 544
12. R. Bendayan, P.T. Ronaldson, D. Gingras, and M. Bendayan In situ localization of P-glycoprotein (ABCB1) in human and rat brain J. Histochem. Cytochem. 54 2006 1159 1167
13. A. Betanzos, M. Huerta, E. Lopez-Bayghen, E. Azuara, J. Amerena, and L. Gonzalez-Mariscal The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells Exp. Cell Res. 292 2004 51 66
14. T.A. Brooks, S.M. Ocheltree, M.J. Seelbach, R.A. Charles, N. Nametz, R.D. Egleton, and T.P. Davis Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain Brain Res. 1120 2006 172 182
15. R.C. Brown, and T.P. Davis Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells Biochem. Biophys. Res. Commun. 327 2005 1114 1123
16. A.M. Butt, H.C. Jones, and N.J. Abbott Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study J. Physiol. 429 1990 47 62
17. D.A. Butterfield, E. Barone, and C. Mancuso Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders Pharmacol. Res. 64 2011 180 186
18. T.A. Cartwright, C.R. Campos, R.E. Cannon, and D.S. Miller Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers J. Cereb. Blood Flow Metab. 33 2013 381 388
19. C. Chu, J.Y. Li, R.J. Boado, and W.M. Pardridge Blood-brain barrier genomics and cloning of a novel organic anion transporter J. Cereb. Blood Flow Metab. 28 2008 291 301
20. M.J. Cipolla, R. Crete, L. Vitullo, and R.D. Rix Transcellular transport as a mechanism of blood-brain barrier disruption during stroke Front. Biosci. 9 2004 777 785
21. L. Cui, X. Zhang, R. Yang, L. Wang, L. Liu, M. Li, and W. Du Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability Brain Res. 1325 2010 164 173
22. S. Dallas, D.S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system Pharmacol. Rev. 58 2006 140 161
23. N.A. de Vries, J. Zhao, E. Kroon, T. Buckle, J.H. Beijnen, and O. van Tellingen P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan Clin. Cancer Res. 13 2007 6440 6449
24. E. Dejana, M.G. Lampugnani, O. Martinez-Estrada, and G. Bazzoni The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permability Int. J. Dev. Biol. 44 2000 743 748
25. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-beta family signaling Nature 425 2003 577 584
26. D. Dogrukol-Ak, V.B. Kumar, J.S. Ryerse, S.A. Farr, S. Verma, N. Nonaka, T. Nakamachi, H. Ohtaki, M.L. Niehoff, J.C. Edwards, S. Shioda, J.E. Morley, and W.A. Banks Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models J. Cereb. Blood Flow Metab. 29 2009 411 422
27. A.S. Fanning, B.J. Jameson, L.A. Jesaitis, and J.M. Anderson The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton J. Biol. Chem. 273 1998 29745 29753
28. G.J. Feldman, J.M. Mullin, and M.P. Ryan Occludin: structure, function and regulation Adv. Drug Deliv. Rev. 57 2005 883 917
29. S. Fischer, M. Wobben, H.H. Marti, D. Renz, and W. Schaper Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1 Microvasc. Res. 63 2002 70 80
30. C. Forster, M. Burek, I.A. Romero, B. Weksler, P.O. Couraud, and D. Drenckhahn Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier J. Physiol. 586 2008 1937 1949
31. M. Furuse, T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita, and S. Tsukita Occludin: a novel integral membrane protein localizing at tight junctions J. Cell Biol. 123 1993 1777 1788
32. M. Furuse, H. Sasaki, and S. Tsukita Manner of interaction of heterogeneous claudin species within and between tight junction strands J. Cell Biol. 147 1999 891 903
33. B. Gao, B. Hagenbuch, G.A. Kullak-Ublick, D. Benke, A. Aguzzi, and P.J. Meier Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier J. Pharmacol. Exp. Ther. 294 2000 73 79
34. C.L. Gibson, K. Srivastava, N. Sprigg, P.M. Bath, and U. Bayraktutan Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions J. Neurochem. 129 2014 816 826
35. P.L. Golden, and W.M. Pardridge P-glycoprotein on astrocyte foot processes of unfized isolated human brain capillaries Brain Res. 819 1999 143 146
36. L. Gonzalez-Mariscal, A. Betanzos, and A. Avila-Flores MAGUK proteins: structure and role in the tight junction Semin. Cell Dev. Biol. 11 2000 315 324
37. C.J. Gottardi, M. Arpin, A.S. Fanning, and D. Louvard The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cellcell contacts Proc. Natl. Acad. Sci. USA 93 1996 10779 10784
38. M.M. Gottesman, C.A. Hrycyna, P.V. Schoenlein, U.A. Germann, and I. Pastan Genetic analysis of the multidrug transporter Annu. Rev. Genet. 29 1995 607 649
39. A. Haarmann, A. Deiss, J. Prochaska, C. Foerch, B. Weksler, I. Romero, P.O. Couraud, G. Stoll, P. Rieckmann, and M. Buttmann Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown PLoS One 5 2010 e13568
40. B. Hagenbuch, and P.J. Meier Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch. 447 2004 653 665
41. A.M. Hartz, and B. Bauer Regulation of ABC transportes at the blood-brain barrier: new targets for CNS therapy Mol. Interv. 10 2010 293 304
42. A.M. Hartz, B. Bauer, E.L. Soldner, A. Wolf, S. Boy, R. Backhaus, I. Mihaljevic, U. Bogdahn, H.H. Klunemann, G. Schuierer, and F. Schlachetzki Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy Stroke 43 2012 514 523
43. V.S. Hau, J.D. Huber, C.R. Campos, R.T. Davis, and T.P. Davis Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception Brain Res. 1018 2004 257 264
44. B.T. Hawkins, T.J. Abbruscato, R.D. Egleton, R.C. Brown, J.D. Huber, C.R. Campos, and T.P. Davis Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution Brain Res. 1027 2004 48 58
45. B.T. Hawkins, and T.P. Davis The blood-brain barrier/neurovascular unit in health and disease Pharmacol. Rev. 57 2005 173 185
46. B.T. Hawkins, S.M. Ocheltree, K.M. Norwood, and R.D. Egleton Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats Neurosci. Lett. 411 2007 1 5
47. A. Hayashi, H. Suzuki, K. Itoh, M. Yamamoto, and Y. Sugiyama Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts Biochem. Biophys. Res. Commun. 310 2003 824 829
48. J.H. Heo, S.W. Han, and S.K. Lee Free radicals as triggers of brain edema formation after stroke Free Radic. Biol. Med. 39 2005 51 70
49. J. Hirrlinger, and R. Dringen Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes Methods Enzymol. 400 2005 395 409
50. J. Hirrlinger, J. Konig, D. Keppler, J. Lindenau, J.B. Schulz, and R. Dringen The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress J. Neurochem. 76 2001 627 636
51. W.H. Hoffman, S.M. Stamatovic, and A.V. Andjelkovic Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis Brain Res. 1254 2009 138 148
52. H. Hong, Y. Lu, Z.N. Ji, and G.Q. Liu Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells J. Neurochem. 98 2006 1465 1473
53. S. Hori, S. Ohtsuki, M. Tachikawa, N. Kimura, T. Kondo, M. Watanabe, E. Nakashima, and T. Terasaki Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s) J. Neurochem. 90 2004 526 536
54. J.D. Huber, K.A. Witt, S. Hom, R.D. Egleton, K.S. Mark, and T.P. Davis Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression Am. J. Physiol. Heart Circ. Physiol. 280 2001 H1241 H1248
55. S.W. Hyun, and Y.S. Jung Hypoxia induces FoxO3-mediated dysfunction of blood-brain barrier Biochem. Biophys. Res. Commun. 450 2014 1638 1642
56. H. Jiao, Z. Wang, Y. Liu, P. Wang, and Y. Xue Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult J. Mol. Neurosci. 44 2011 130 139
57. J.C. Kalvass, J.W. Polli, D.L. Bourdet, B. Feng, S.M. Huang, X. Liu, Q.R. Smith, L.K. Zhang, and M.J. Zamek-Gliszczynski Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position Clin. Pharmacol. Ther. 94 2013 80 94
58. M. Kassan, M.J. Montero, and M.A. Sevilla In vitro antioxidant activity of pravastatin provides vascular protection Eur. J. Pharmacol. 630 2010 107 111
59. M.Y. Kim, T. Zhang, and W.L. Kraus Poly(ADP-ribosyl)ation by PARP-1: PAR-laying NAD+ into a nuclear signal Genes Dev. 19 2005 1951 1967
60. B. Kis, T. Isse, J.A. Snipes, L. Chen, H. Yamashita, Y. Ueta, and D.W. Busija Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers J. Appl. Physiol. 100 2006 1392 1399
61. H. Kodaira, H. Kusuhara, J. Ushiki, E. Fuse, and Y. Sugiyama Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone J. Pharmacol. Exp. Ther. 333 2010 788 796
62. H. Kusuhara, and Y. Sugiyama Active efflux across the blood-brain barrier: role of the solute carrier family NeuroRx 2 2005 73 85
63. F. Lacaz-Vieira, M.M. Jaeger, P. Farshori, and B. Kachar Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing J. Membr. Biol. 168 1999 289 297
64. M.G. Lampugnani, and E. Dejana The control of endothelial cell functions by adherens junctions Novartis Found. Symp. 283 2007 4 13
65. G. Lee, K. Babakhanian, M. Ramaswamy, A. Prat, K. Wosik, and R. Bendayan Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems Pharm. Res. 24 2007 1262 1274
66. Y.J. Lee, H. Kusuhara, J.W. Jonker, A.H. Schinkel, and Y. Sugiyama Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein J. Pharmacol. Exp. Ther. 312 2005 44 52
67. M. Leggas, M. Adachi, G.L. Scheffer, D. Sun, P. Wielinga, G. Du, K.E. Mercer, Y. Zhuang, J.C. Panetta, B. Johnston, R.J. Scheper, C.F. Stewart, and J.D. Schuetz Mrp4 confers resistance to topotecan and protects the brain from chemotherapy Mol. Cell. Biol. 24 2004 7612 7621
68. E.I. Lepist, V.L. Damaraju, J. Zhang, W.P. Gati, S.Y. Yao, K.M. Smith, E. Karpinski, J.D. Young, K.H. Leung, and C.E. Cass Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1 Drug Metab. Dispos. 41 2013 916 922
69. E.M. Leslie, R.G. Deeley, and S.P. Cole Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense Toxicol. Appl. Pharmacol. 204 2005 216 237
70. H. Li, A. Gao, D. Feng, Y. Wang, L. Zhang, Y. Cui, B. Li, Z. Wang, and G. Chen Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood-brain barrier integrity during experimental cerebral ischemia-reperfusion injury Transl. Stroke Res. 5 2014 618 626
71. W. Li, C. Busu, M.L. Circu, and T.Y. Aw Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis Int. J. Cell Biol. 2012 2012 434971
72. J.J. Lochhead, G. McCaffrey, C.E. Quigley, J. Finch, K.M. DeMarco, N. Nametz, and T.P. Davis Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation J. Cereb. Blood Flow Metab. 30 2010 1625 1636
73. J.J. Lochhead, G. McCaffrey, L. Sanchez-Covarrubias, J.D. Finch, K.M. DeMarco, C.E. Quigley, T.P. Davis, and P.T. Ronaldson Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain Am. J. Physiol. Heart Circ. Physiol. 302 2012 H582 H593
74. Q. Ma Role of Nrf2 in oxidative stress and toxicity Annu. Rev. Pharmacol. Toxiciol. 53 2013 401 426
75. J.M. Maher, M.Z. Dieter, L.M. Aleksunes, A.L. Slitt, G. Guo, Y. Tanaka, G.L. Scheffer, J.Y. Chan, J.E. Manautou, Y. Chen, T.P. Dalton, M. Yamamoto, and C.D. Klaassen Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway Hepatology 46 2007 1597 1610
76. K.S. Mark, and T.P. Davis Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1485 H1494
77. G. McCaffrey, W.D. Staatz, L. Sanchez-Covarrubias, J.D. Finch, K. DeMarco, M.L. Laracuente, P.T. Ronaldson, and T.P. Davis P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia J. Neurochem. 122 2012 962 975
78. G. McCaffrey, W.D. Staatz, C.A. Quigley, N. Nametz, M.J. Seelbach, C.R. Campos, T.A. Brooks, R.D. Egleton, and T.P. Davis Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo J. Neurochem. 103 2007 2540 2555
79. G. McCaffrey, M.J. Seelbach, W.D. Staatz, N. Nametz, C. Quigley, C.R. Campos, T.A. Brooks, and T.P. Davis Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia J. Neurochem. 106 2008 2395 2409
80. W. Meng, and M. Takeichi Adherens junction: molecular architecture and regulation Cold Spring Harb. Perspect. Biol. 1 2009 a002899
81. D.S. Miller, S.N. Nobmann, H. Gutmann, M. Toeroek, J. Drewe, and G. Fricker Xenobiotic transport across isolated brain microvessels studied by confocal microscopy Mol. Pharmacol. 58 2000 1357 1367
82. T. Minich, J. Riemer, J.B. Schulz, P. Wielinga, J. Wijnholds, and R. Dringen The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes J. Neurochem. 97 2006 373 384
83. M. Miyajima, H. Kusuhara, M. Fujishima, Y. Adachi, and Y. Sugiyama Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice Drug Metab. Dispos. 39 2011 814 819
84. A. Muruganandam, C. Smith, R. Ball, T. Herring, and D. Stanimirovic Glutathione homeostasis and leukotriene-induced permeability in human blood-brain barrier endothelial cells subjected to in vitro ischemia Acta Neurochir. Suppl. 76 2000 29 34
85. K. Namba, Y. Takeda, K. Sunami, and M. Hirakawa Temporal profiles of the levels of endogenous antioxidants after four-vessel occlusion in rats J. Neurosurg. Anesthesiol. 13 2001 131 137
86. C. Nito, H. Kamada, H. Endo, K. Niizuma, D.J. Myer, and P.H. Chan Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion J. Cereb. Blood Flow Metab. 28 2008 1686 1696
87. S. Ohtsuki, C. Ikeda, Y. Uchida, Y. Sakamoto, F. Miller, F. Glacial, X. Decleves, J.M. Scherrmann, P.O. Couraud, Y. Kubo, M. Tachikawa, and T. Terasaki Quantitative targeted absolute proteomic analysis of transporters and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model Mol. Pharm. 10 2013 289 296
88. W.H. Oldendorf, M.E. Cornford, and W.J. Brown The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat Ann. Neurol. 1 1977 409 417
89. A. Ose, M. Ito, H. Kusuhara, K. Yamatsugu, M. Kanai, M. Shibasaki, M. Hosokawa, J.D. Schuetz, and Y. Sugiyama Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4) Drug Metab. Dispos. 37 2009 315 321
90. A. Ose, H. Kusuhara, C. Endo, K. Tohyama, M. Miyajima, S. Kitamura, and Y. Sugiyama Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier Drug Metab. Dispos. 38 2010 168 176
91. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol. Rev. 87 2007 315 424
92. A. Palmeira, E. Sousa, M.H. Vasconcelos, and M.M. Pinto Three decades of Pgp inhibitors: skimming through several generations and scaffolds Curr. Med. Chem. 19 2012 1946 2025
93. E.M. Park, J.H. Choi, J.S. Park, M.Y. han, and Y.M. Park Measurement of glutathione oxidation and 8-hydroxy-2′-deoxyguanosine accumulation in the gerbil hippocampus following global ischemia Brain Res. Protoc. 6 2000 25 32
94. N.N. Pathak, V. Balaganur, M.C. Lingaraju, V. Kant, N. Latief, A.S. More, D. Kumar, D. Kumar, and S.K. Tandan Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels Neurochem. Int. 68 2014 1 9
95. C.C. Paulusma, M.A. van Geer, R. Evers, M. Heijn, R. Ottenhoff, P. Borst, and R.P. Oude Elferink Canalicular multispecific organic transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione Biochem. J. 338 1999 393 401
96. D.R. Pillai, M.S. Dittmar, D. Baldaranov, R.M. Heidemann, E.C. Henning, G. Schulerer, U. Bogdahn, and F. Schlachetzki Cerebral ischemia-reperfusion injury in rats - a 3T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation J. Cereb. Blood Flow Metab. 29 2009 1846 1855
97. M. Plateel, M.P. Dehouck, G. Torpier, R. Cecchelli, and E. Tessier Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer J. Neurochem. 65 1995 2138 2145
98. J. Ponce, N.P. de la Ossa, O. Hurtado, M. Millan, J.F. Arenillas, A. Davalos, and T. Gasull Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection Stroke 39 2008 1269 1275
99. H. Potschka Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51 2010 1333 1347
100. Z. Redzic Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences Fluids Barriers CNS 8 2011 3
101. F.K. Riesen, B. Rothen-Rutishauser, and H. Wunderli-Allenspach A ZO1-GFP fusion protein to study the dynamics of tight junctions in living cells Histochem. Cell Biol. 117 2002 307 315
102. M. Rius, J. Hummel-Eisenbeiss, A.F. Hofmann, and D. Keppler Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G640 G649
103. L.M. Roberts, D.S. Black, C. Raman, K. Woodford, M. Zhou, J.E. Haggerty, A.T. Yan, S.E. Cwirla, and K.K. Grindstaff Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation Neuroscience 155 2008 423 438
104. R.W. Robey, K.K. Polgar, O. Dohse, M. Fetsch, P. Dean, and M. Bates, S.E. ABCG2: a perspective Adv. Drug Deliv. Rev. 61 2009 3 13
105. K.D. Rochfort, L.E. Collins, R.P. Murphy, and P.M. Cummins Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions PLoS One 9 2014 e101815
106. D.F. Rolfe, and G.C. Brown Cellular energy utilization and molecular origin of standard metabolic rate in mammals Physiol. Rev. 77 1997 731 758
107. P.T. Ronaldson, and R. Bendayan HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells J. Neurochem. 106 2008 1298 1313
108. P.T. Ronaldson, and T.P. Davis Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke Curr. Pharm. Des. 18 2012 3624 3644
109. P.T. Ronaldson, and T.P. Davis Targeted drug delivery to treat pain and cerebral hypoxia Pharmacol. Rev. 65 2013 291 314
110. P.T. Ronaldson, K.M. DeMarco, L. Sanchez-Covarrubias, C.M. Solinsky, and T.P. Davis Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain J. Cereb. Blood Flow Metab. 29 2009 1084 1098
111. P.T. Ronaldson, J.D. Finch, K.M. DeMarco, C.E. Quigley, and T.P. Davis Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier J. Pharmacol. Exp. Ther. 336 2011 827 839
112. P.T. Ronaldson, Y. Persidsky, and R. Bendayan Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection Glia 56 2008 1711 1735
113. D. Salvemini, T.M. Doyle, and S. Cuzzocrea Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation Biochem. Soc. Trans. 34 2006 965 970
114. L. Sanchez-Covarrubias, L.M. Slosky, B.J. Thompson, T.P. Davis, and P.T. Ronaldson Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr. Pharm. Des. 20 2014 1422 1449
115. L. Sanchez-Covarrubias, L.M. Slosky, B.J. Thompson, Y. Zhang, M.L. Laracuente, K.M. DeMarco, P.T. Ronaldson, and T.P. Davis P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac PLoS One 9 2014 e88516
116. K.E. Sandoval, and K.A. Witt Blood-brain barrier tight junction permeability and ischemic stroke Neurobiol. Dis. 32 2008 200 219
117. F. Schlachetzki, and W.M. Pardridge P-glycoprotein and caveolin-1alpha in endothelium and astrocytes of primate brain Neuroreport 14 2003 2041 2046
118. G. Schreibelt, G. Kooij, A. Reijerkerk, R. van Doorn, S.I. Gringhuis, S. van der Pol, B.B. Weksler, I.A. Rmero, P.O. Couraud, J. Piontek, I.E. Blasig, C.D. Dijkstra, E. Ronken, and H.E. de Vries Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling FASEB J. 21 2007 3666 3676
119. M.J. Seelbach, T.A. Brooks, R.D. Egleton, and T.P. Davis Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein J. Neurochem. 102 2007 1677 1690
120. N. Sladojevic, S.M. Stamatovic, R.F. Keep, J.J. Grailer, J.V. Sarma, P.A. Ward, and A.V. Andjelkovic Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury Neurobiol. Dis. 67 2014 57 70
121. L.M. Slosky, B.J. Thompson, L. Sanchez-Covarrubias, Y. Zhang, M.L. Laracuente, T.W. Vanderah, P.T. Ronaldson, and T.P. Davis Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism Mol. Pharmacol. 84 2013 774 786
122. M. Sochocka, E.S. Koutsouraki, K. Gasiorowski, and J. Leszek Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimers disease: a new approach to therapy CNS Neurol. Disord. Drug Targets 12 2013 870 881
123. E. Steiner, G.U. Enzmann, R. Lyck, S. Lin, M.A. Ruegg, S. Kroger, and B. Engelhardt The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions Cell Tissue Res. 358 2014 465 479
124. B.R. Stevenson, J.D. Siliciano, M.S. Mooseker, and D.A. Goodenough Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia J. Cell Biol. 103 1986 755 766
125. A. Strasser, D. Stanimirovic, N. Kawai, R.M. McCarron, and M. Spatz Hypoxia modulates free radical formation in brain microvascular endothelium Acta Neurochir. Suppl. 70 1997 8 11
126. T. Sugiura, Y. Kato, and A. Tsuji Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition J. Control. Release 116 2006 238 246
127. D. Sugiyama, H. Kusuhara, H. Taniguchi, S. Ishikawa, Y. Nozaki, H. Aburatani, and Y. Sugiyama Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine J. Biol. Chem. 278 2003 43489 43495
128. N. Tadepalle, Y. Koehler, M. Brandmann, N. Meyer, and R. Dringen Arsenite stimulates glutathione export and glycolytic flux in viable primary rat brain astrocytes Neurochem. Int. 76 2014 1 11
129. Y. Takenaga, N. Takagi, K. Murotomi, K. Tanonaka, and S. Takeo Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia J. Cereb. Blood Flow Metab. 29 2009 1099 1108
130. T. Taogoshi, A. Nomura, T. Murakami, J. Nagai, and M. Takano Transport of prostaglandin E1 across the blood-brain barrier in rats J. Pharm. Pharmacol. 57 2005 61 66
131. B.J. Thompson, and P.T. Ronaldson Drug delivery to the ischemic brain Adv. Pharmacol. 71 2014 165 202
132. B.J. Thompson, L. Sanchez-Covarrubias, L.M. Slosky, Y. Zhang, M.L. Laracuente, and P.T. Ronaldson Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery J. Cereb. Blood Flow Metab. 34 2014 699 707
133. T. Tokui, D. Nakai, R. Nakagomi, H. Yawo, T. Abe, and Y. Sugiyama Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2 Pharm. Res. 16 1999 904 908
134. N. Tournier, X. Decleves, B. Saubamea, J.M. Scherrmann, and S. Cisternino Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology Curr. Pharm. Des. 17 2011 2829 2842
135. Y. Uchida, S. Ohtsuki, Y. Katsukura, C. Ikeda, T. Suzuki, J. Kamiie, and T. Terasaki Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors J. Neurochem. 117 2011 333 345
136. M. Ueno, T. Nakagawa, C.L. Huang, M. Ueki, T. Kusaka, N. Hosomi, K. Kanenishi, M. Onodera, B. Wu, and H. Sakamoto The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model Neuropathol. Appl. Neurobiol. 35 2009 147 155
137. K. Umeda, T. Matsui, M. Nakayama, K. Furuse, H. Sasaki, M. Furuse, and S. Tsukita Establishment and characterization of cultured epithelial cells lacking expression of ZO-1 J. Biol. Chem. 279 2004 44785 44794
138. A.E. van Herwaarden, J.W. Jonker, E. Wagenaar, R.F. Brinkhuis, J.H. Schellens, J.H. Beijnen, and A.H. Schinkel The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cancer Res. 63 2003 6447 6452
139. S. Vemula, K.E. Roder, T. Yang, G.J. Bhat, T.J. Thekkumkara, and T.J. Abbruscato A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation J. Pharmacol. Exp. Ther. 328 2009 487 495
140. D. Vestweber VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation Arterioscler. Thromb. Vasc. Biol. 28 2008 223 232
141. N. Vijay, and M.E. Morris Role of monocarboxylate transporters in drug delivery to the brain Curr. Pharm. Des. 20 2014 1487 1498
142. D. Virgintino, D. Robertson, M. Errede, V. Benagiano, F. Girolamo, E. Maiorano, L. Roncali, and M. Bertossi Expression of P-glycoprotein in human cerebral cortex microvessels J. Histochem. Cytochem. 50 2002 1671 1676
143. V. Vollrath, A.M. Wielandt, M. Iruretagoyena, and J. Chianale Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene Biochem. J. 395 2006 599 609
144. B.K. Wacker, A.B. Freie, J.L. Perfater, and J.M. Gidday Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance J. Cereb. Blood Flow Metab. 32 2012 1014 1023
145. X. Wang, C.R. Campos, J.C. Peart, L.K. Smith, J.L. Boni, R.E. Cannon, and D.S. Miller Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers J. Neurosci. 34 2014 8585 8593
146. X.S. Wang, H.L. Fang, Y. Chen, S.S. Liang, Z.G. Zhu, Q.Y. Zeng, J. Li, H.G. Xu, B. Shao, J.C. He, S.T. Hou, and R.Y. Zheng Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse Eur. J. Pharmacol. 736 2014 70 76
147. P. Wang, Y. Liu, X. Shang, and Y. Xue CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein J. Mol. Neurosci. 43 2011 485 492
148. D.E. Westholm, D.R. Salo, K.J. Viken, J.N. Rumbley, and G.W. Anderson The blood-brain barrier thyroxine transporter organic anion-transporting polypeptide 1c1 displays atypical transport kinetics Endocrinology 150 2009 5153 5162
149. D.E. Westholm, D.D. Stenehjem, J.N. Rumbley, L.R. Drewes, and G.W. Anderson Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs Endocrinology 150 2009 1025 1032
150. D.W. Williams, T.M. Calderon, L. Lopez, L. Carvallo-Torres, P.J. Gaskill, E.A. Eugenin, S. Morgello, and J.W. Berman Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis PLoS One 8 2013 e69270
151. M.J. Williams, M.B. Lowrie, J.P. Bennett, J.A. Firth, and P. Clark Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse Brain Res. 1058 2005 62 72
152. C.L. Willis, R.B. Camire, S.A. Brule, and D.E. Ray Partial recovery of the damaged rat blood-brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss Neuroscience 250 2013 773 785
153. C.L. Willis, L. Leach, G.J. Clarke, C.C. Nolan, and D.E. Ray Reversible disruption of tight junction complexes in the rat blood-brain barrier following transitory focal astrocyte loss Glia 48 2004 1 13
154. C.L. Willis, D.S. Meske, and T.P. Davis Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation J. Cereb. Blood Flow Metab. 30 2010 1847 1859
155. C.L. Willis, C.C. Nolan, S.N. Reith, T. Lister, M.J. Prior, C.J. Guerin, G. Mavroudis, and D.E. Ray Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact Glia 45 2004 325 337
156. K.A. Witt, K.S. Mark, S. Hom, and T.P. Davis Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression Am. J. Physiol. Heart Circ. Physiol. 285 2003 H2820 H2831
157. K.A. Witt, K.S. Mark, J. Huber, and T.P. Davis Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress J. Neurochem. 92 2005 203 214
158. K.A. Witt, K.S. Mark, K.E. Sandoval, and T.P. Davis Reoxygenation stresson blood-brain barrier paracellular permeability and edema in the rat Microvasc. Res. 75 2008 91 96
159. W.G. Wood, G.P. Eckert, U. Igbavboa, and W.E. Muller Statins and neuroprotection: a prescription to move the field forward Ann. N. Y. Acad. Sci. 1199 2010 69 76
160. S. Xu, J. Weerachayaphorn, S.Y. Cai, C.J. Soroka, and J.L. Boyer Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G126 G135
161. D. Yang, R.A. Knight, Y. Han, K. Karki, J. Zhang, M. Chopp, and D.M. Seyfried Statins protect the blood-brain barrier acutely after experimental intracerebral hemorrhage J. Behav. Brain Sci. 3 2013 100 106
162. Y. Yang, J.F. Thompson, S. Taheri, V.M. Salayandia, T.A. McAvoy, J.W. Hill, Y. Yang, E.Y. Estrada, and G.A. Rosenberg Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery J. Cereb. Blood Flow Metab. 33 2013 1104 1114
163. W.L. Yeh, C.J. Lin, and W.M. Fu Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia Mol. Pharmacol. 73 2008 170 177
164. D. Yeung, J.L. Manias, D.J. Stewart, and S. Nag Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown Acta Neuropathol. 115 2008 635 642
165. S. Yousif, C. Chaves, S. Potin, I. Margalli, J.M. Scherrmann, and X. Decleves Induction of P-glcyoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 acitivation J. Neurochem. 123 2012 491 503
166. S. Yousif, B. Saubamea, S. Cisternino, C. Marie-Claire, S. Dauchy, J.M. Scherrmann, and X. Decleves Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein J. Neurochem. 107 2008 647 657
167. C.M. Zehendner, L. Librizzi, J. Hedrich, N.M. Bauer, E.A. Angamo, M. de Curtis, and H.J. Luhmann Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption PLoS One 8 2013 e82823
168. Y. Zhang, J.D. Schuetz, W.F. Elmquist, and D.W. Miller Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells J. Pharmacol. Exp. Ther. 311 2004 449 455
169. R. Zhao, T.J. Raub, G.A. Sawada, S.C. Kasper, J.A. Bacon, A.S. Bridges, and G.M. Pollack Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier Drug Metab. Dispos. 37 2009 1251 1258
170. L. Zhou, K. Schmidt, F.R. Nelson, V. Zelesky, M.D. Troutman, and B. Feng The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice Drug Metab. Dispos. 37 2009 946 955